affiliation not provided to SSRN
Leishmaniasis, pharmacomodulation, 4, 5-dihydrofuran, amidoxime, manganese (III) acetate
naphthoquinone, endoperoxide, Mn(acac)3, stereoisomers, Plasmodium falciparum, therapeutic chemistry, Rational drug design